<div id="readability-page-1"><div><div>Alexandr Wang, the 28-year-old Scale AI founder now heading to Meta Platforms’ META new &#34;super-intelligence&#34; lab says artificial-intelligence models already possess insights that science cannot match and that makes it “a strange time to be a scientist, but an exciting time for science.”What Happened: Wang told a Y Combinator audience the advantage is clearest in biology, where “there's probably intuitions that the models have about biology that humans don't even have because they have this different form of intelligence.”He narrated a story that predicted AI systems will soon run &#34;all the frontiers of R&amp;D,&#34; leaving human researchers to &#34;look at the discoveries the AIs make and try to understand them.&#34;The comments arrive days after Meta paid about $14 billion for a 49% stake in Scale and hired Wang to accelerate Mark Zuckerberg's push for artificial general intelligence. Meta's move follows a wider trend. Alphabet Inc. GOOG GOOGL Google unveiled a Gemini-powered &#34;AI co-scientist&#34; in February aimed at speeding biomedical breakthroughs. Academic work already shows AI models outperforming humans on protein-folding and genetic-sequence tasks, raising hopes for faster drug discovery.&#34;Areas like biology will fuel breakthroughs in medicine and healthcare,&#34; Wang said, adding that the rest of the economy will &#34;chug along giving humans what they want.&#34;See also: Meta’s ‘Superintelligence’ Lab Hire Alexandr Wang Says He’ll Wait for Elon Musk’s Neuralink Before Having Kids — Here’s WhyWhy It Matters: Venture investors share that view. CB Insights counts 370 AI-biology startups worth a combined $60 billion, up 28% from 2023.Meanwhile, Wang's arrival at Meta hihglights the company's escalating talent hunt. Reuters reported Meta recently dangled $100 million signing bonuses to lure OpenAI staff. Y Combinator president Garry Tan called Wang &#34;an inspiration to the next generation of founders&#34; in a post on X.Even though critics warn dual-use risks rise as models master bio-engineering, prompting calls for guardrails even inside Meta's lab, Wang argues embracing the shift is essential.Photo Courtesy: Gorodenkoff on Shutterstock.comRead next: He Makes $150K, She Makes $63K — So Why Did They Use A HELOC To Pay Off His $45K Debt? Suze Orman Weighs In</div></div></div>

META

Alexandr Wang, founder of Scale AI and now leading Meta's new "super-intelligence" lab, claims AI models possess insights surpassing human understanding, particularly in biology. He predicts AI will dominate R&D, leaving humans to interpret AI discoveries. Meta's recent $14 billion investment in Scale reflects a broader trend in AI-driven biomedical advancements. Despite concerns over bio-engineering risks, Wang emphasizes the importance of adapting to this shift. The rise of AI-biology startups, valued at $60 billion, underscores the growing intersection of AI and healthcare.

- Alexandr Wang, founder of Scale AI, emphasizes that AI models possess unique insights in biology, surpassing human understanding, which he believes is an exciting time for science.  
- His comments follow Meta's $14 billion investment in Scale and highlight a trend where AI is expected to drive research and development, particularly in medicine and healthcare.  
- Despite concerns over bio-engineering risks, Wang advocates for embracing AI advancements, as venture investors recognize the growing value of AI-biology startups, now worth $60 billion.  

Why Meta's 'Superintelligence' Project Lead Alexandr Wang Says It Is A Strange Time To Be A Scientist